Patient groups want CMS to require that insurers offer exchange plans that don’t include deductibles, that count drug company financial assistance toward deductibles and that spread out cost-sharing over the year. Insurers oppose those mandates. Those are among the requests from 40 patient groups that jointly commented on a proposed rule for the 2022 Notice of Benefits and Payment Parameters. CMS’ proposed rule restarts the standardized plan option for the federal exchange that the Obama administration originally pursued. The agency...